|
Cochlear Limited is a medical technology company that designs and manufactures implantable hearing devices. The company operates through three primary business segments: Cochlear Implants, Services, and Acoustics. Its core product line includes the Nucleus Nexa System, the Nucleus Kanso 3 Sound Processor, and the Osia Implant for acoustic neuromas. The Services segment provides sound processor upgrades and clinical support, while the Acoustics segment offers the Osia Implant and the Baha 7 Sound Processor for bone conduction hearing. Cochlear serves patients with hearing loss in developed and emerging markets, with a specific strategic focus on the adults and seniors demographic. The company utilizes a Connected Care ecosystem, including Remote Check and Remote Assist tools, to support healthcare professionals in patient management. Cochlear holds an investment in Saluda, a subsidiary involved in hearing technology. The company's products are distributed globally, with significant operations in Europe, Asia Pacific, and the United States. Summarised from the company's own disclosures, fiscal year ended Dec 2025 |
Industry Health Care Equipment & Services | Homepage cochlear.com |
| Sector Healthcare | IR page — | |
|
Tags
cochlear implants, acoustic implants, sound processors, bone conduction, hearing loss, remote care, medical technology, Nucleus Nexa, Nucleus Kanso 3, Osia Implant, Baha 7, Osia 2(I), Nucleus 8, Nucleus 7, Saluda, Remote Check, Remote Assist, Connected Care
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | A$ 10.005B |
| Market cap (USD) | $ 6.789B |
| P/E | 60.16 |
| PEG | — |
| P/BV | 6.20 |
| P/S | 6.07 |
| P/OCF | 27.19 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 8.7% |
| ROI | 10.3% |
| ROIC | 8.7% |
| Profit margin | — |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | — |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | -12.5% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 1.648B | 1.498B | 1.321B | 1.427B | 1.364B | 1.254B | 1.131B | 925.63M | 804.936M | 752.721M | 778.996M | 809.646M | 734.803M |
| Net profit | 147.3M | 388.9M | 289.1M | 323.8M | -238.3M | 276.7M | 245.8M | 223.6M | 188.921M | 145.84M | 93.709M | 132.563M | 56.803M | 180.114M | 155.152M |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpAnnouncements lodged with ASX, newest first, routine forms (director and substantial-holding notices, daily buy-back and quotation notices) included. The link opens the announcement on ASX. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Cochlear Limited
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVSD | 0.04% | 1,651 | $ 166.538K | Nov 16, 2026 |
| JSTC | 0.03% | 865 | $ 88.059K | Nov 17, 2026 |
| NTSI | 0.02% | 995 | $ 83.927K | Jun 30, 2026 |
| AVDE | 0.01% | 16,188 | $ 1.633M | Nov 16, 2026 |
| DFAX | 0.01% | 9,295 | $ 968.347K | Nov 12, 2026 |
| DFAI | 0.00% | 5,566 | $ 579.862K | Nov 12, 2026 |
| DFIC | 0.00% | 4,613 | $ 480.579K | Nov 12, 2026 |